Organization

Stephenson Cancer Center at the University of Oklahoma

2 abstracts

Abstract
Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study.
Org: Stephenson Cancer Center at the University of Oklahoma, Macquarie University Cancer Institute, Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China, Hunan Provincial People's Hospital, Changsha, China, Linyi Cancer Hospital,